Julie Smith sold $2.8M of Exelixis (EXEL)

Executed Feb 27 2025, disclosed Feb 28 2025, 1 day later.

Value, as filed

$2.8M

73,808 sh across 2 lots

Executed

Feb 27 2025

the trade date, as filed

Disclosed

Feb 28 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JS Julie Smith Director profile →

Julie Smith (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $4.7M of EXEL (106,539 sh across 3 lots, as filed), executed Feb 17.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Julie Smith in EXEL

EXELSALE Exelixis, Inc. $4.7M
106,539 sh across 3 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET